Amgen

Open Collage in a new Window

This page contains text from Wikipedia, the Free Encyclopedia - http://en.wikipedia.org/wiki/Amgen

This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.

Biotechnology by Amgen: Innovation

Duration: 2:13
Updated: 15 Jul 2014
author: Amgen

Amgen staff members discuss innovation in manufacturing biologic medicines. http://www.BiotechnologybyAmgen.com.

http://wn.com/Biotechnology_by_Amgen_Innovation

Play Fullscreen

Strategic Business Insights: An interview with Amgen CEO Kevin Sharer

Duration: 6:21
Updated: 15 Aug 2014
author: Tuck School of Business

Kevin Sharer, CEO of Amgen, talks about the two most critical strategic decisions that had major impact on the success of his biotech firm, as well as the mi...

http://wn.com/Strategic_Business_Insights_An_interview_with_Amgen_CEO_Kevin_Sharer

Play Fullscreen

The Amgen Difference

Duration: 2:23
Updated: 25 Aug 2014
author: Amgen

Amgen is a biotechnology pioneer with a mission to serve patients. In this video, Amgen staff from around the world share their thoughts on the corporate val...

http://wn.com/The_Amgen_Difference

Play Fullscreen

Disturbing Report: Both Parties In Bed With Amgen

Duration: 10:00
Updated: 12 Aug 2014
author: The Young Turks

A stunning New York Times report looks at how biotech company Amgen (which has 74 lobbyists) used financial contributions to Congress to pump up their profit...

http://wn.com/Disturbing_Report_Both_Parties_In_Bed_With_Amgen

Play Fullscreen

Amgen Tour Of California 2015 | Stage 5 Preview

Duration: 7:49
Updated: 01 May 2015

Stage 5 of the 2015 Tour of California takes the riders 154km from Santa Barbara to Santa Clarita. Click here to subscribe to GCN: http://gcn.eu/SubscribeToGCN This undulating stage will take in over 2000m of elevation and could see the opportunity for a breakaway to steal the show over what will be a class field of sprinters, including Mark Cavendish, Marcel Kittel and Peter Sagan. Dan was joined (for some of the route at least) by his former teammate Dave Zabriskie. They tackled the infamous Balcom Canyon Road, which features grades of up to 20%. The race finishes near Six Flags Magic Mountain - they'll pass by the theme park on the way to a rollercoaster ride of a finish in Santa Clarita. Music: Lower 48 - Long Time Coming: http://gcn.eu/1FC7nnc Real Fur - Animal: http://gcn.eu/1JWzXyX One Girl One Boy- Making A Fool: http://gcn.eu/1GMWiBl Deadly Avenger - - Soulblade: http://gcn.eu/1PcxgL2 Jessica Voccia - Game Of Death Buy GCN Cycling Kit! Click here: http://gcn.eu/BuyGCNKitYT Get GCN T-Shirts and hoodies: http://gcn.eu/buy_GCN_stuff About GCN: The Global Cycling Network puts you in the centre of the action: from the iconic climbs of Alpe D’Huez and Mont Ventoux to the cobbles of Flanders, everywhere there is road or pavé, world-class racing and pro riders, we will be there bringing you action, analysis and unparalleled access every week, every month, and every year. We show you how to be a better cyclist with our bike maintenance videos, tips for improving your cycling, cycling top tens, and not forgetting the weekly GCN Show. Join us on YouTube’s biggest and best cycling channel to get closer to the action and improve your riding! Welcome to the Global Cycling Network | Inside cycling Thanks to our sponsors: Santini cycling kit: http://gcn.eu/BuyGCNKitYT Kask helmets: http://gcn.eu/1FrbcHK fi’zi:k shoes: http://gcn.eu/1tsXI7S Garmin: http://gcn.eu/1GtylOY Youtube Channel - http://gcn.eu/gcnYT Facebook - http://gcn.eu/gcnFb Google+ - http://gcn.eu/gcnGPlus Twitter - http://gcn.eu/gcnTW Leave us a comment below!

http://wn.com/Amgen_Tour_Of_California_2015_|_Stage_5_Preview

Play Fullscreen

Amgen Oncology -- Taking on the Toughest Cancers

Duration: 1:27
Updated: 27 Jul 2014
author: Amgen

For more than 30 years, Amgen has been at the forefront in providing the oncology and hematology community with supportive care options. Today, our areas of ...

http://wn.com/Amgen_Oncology_--_Taking_on_the_Toughest_Cancers

Play Fullscreen

Dr. Joe Miletich of Amgen explains biologics, why the future is promising

Duration: 2:08
Updated: 30 Jan 2014
author: PhRMAPress

Dr. Joe Miletich, Senior Vice President of Research & Development at Amgen, discusses the science behind biologics. The more we understand how the human body...

http://wn.com/Dr._Joe_Miletich_of_Amgen_explains_biologics,_why_the_future_is_promising

Play Fullscreen

Biotechnology by Amgen: Quality Processes

Duration: 2:06
Updated: 06 Jun 2013
author: Amgen

Amgen staff members discuss the processes in place to help ensure quality from the start. http://www.BiotechnologybyAmgen.com.

http://wn.com/Biotechnology_by_Amgen_Quality_Processes

Play Fullscreen

Amgen Science

Duration: 2:41
Updated: 12 Feb 2015

Some of the greatest advances in science are unfolding now inside Amgen. Watch the future of biotechnology as it unfolds and hear stories from the scientists making it happen at http://www.AmgenScience.com.

http://wn.com/Amgen_Science

Play Fullscreen

Amgen - Answers Within Us

Duration: 2:10
Updated: 26 Jan 2015

In 2015, Amgen celebrates 35 years of pioneering science to help patients. At Amgen, we believe in a “biology first” approach. We use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from disease. Amgen believes that the cure for disease can be found inside each and every one of us. So, to help people we must focus on people.

http://wn.com/Amgen_-_Answers_Within_Us

Play Fullscreen

About Amgen

Duration: 1:36
Updated: 23 Jul 2014
author: Amgen

Amgen leaders discuss Amgen's commitment to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manu...

http://wn.com/About_Amgen

Play Fullscreen

2014 Amgen Tour of California Circuit Race P/B SRAM

Duration: 71:06
Updated: 30 Jul 2014
author: AmgenTourofCali

2014 Women's race in Sacramento, CA.

http://wn.com/2014_Amgen_Tour_of_California_Circuit_Race_P_B_SRAM

Play Fullscreen

Last 3km of Stage 8 of Amgen Tour of California

Duration: 3:27
Updated: 05 Sep 2014
author: SHIMANORaceTV

Get inside the peloton for the last 3km of stage 8 of the Amgen Tour of California. Majority of clip from Koen de Kort saddle cam. Last 150m filmed from John...

http://wn.com/Last_3km_of_Stage_8_of_Amgen_Tour_of_California

Play Fullscreen

Amgen Scholars Program

Duration: 4:54
Updated: 06 Jun 2013
author: Amgen

Amgen Scholars is a $34 million, eight-year program that provides pivotal research experiences for undergraduate students interested in pursuing a graduate d...

http://wn.com/Amgen_Scholars_Program

Play Fullscreen

Amgen Scholars Program: Vladan Martinović

Duration: 2:56
Updated: 07 Nov 2014

Europe Amgen Scholar Alumnus Vladan Martinović shares his story about participating in the program as an Amgen Scholar at the University of Cambridge in 2010. Now back as a PhD candidate at University of Cambridge, Martinović says “The Amgen Scholars Program was one of the most important things that has happened to me.” The Amgen Scholars Program provides young scientists across the globe access and opportunity through cutting-edge research experiences and exposure to biotechnology and drug discovery. To learn more, visit: http://www.amgenscholars.com

http://wn.com/Amgen_Scholars_Program_Vladan_Martinović

Play Fullscreen

2014 Amgen Tour of California Stage 8 Presented by Amgen - Highlights

Duration: 4:45
Updated: 07 Jul 2014
author: AmgenTourofCali

Stage 8.

http://wn.com/2014_Amgen_Tour_of_California_Stage_8_Presented_by_Amgen_-_Highlights

Play Fullscreen

Amgen Scholar Program: Prisma Lopez

Duration: 2:13
Updated: 06 Nov 2014

Amgen Scholar Prisma Lopez shares her story about participating in the program as an Amgen Scholar at Columbia University in 2012. “The Amgen Scholars Program gave me the chance of a lifetime as an undergraduate that would not have otherwise been available to me,” says Lopez.The Amgen Scholars Program provides young scientists across the globe access and opportunity through cutting-edge research experiences and exposure to biotechnology and drug discovery. To learn more, visit: http://www.amgenscholars.com

http://wn.com/Amgen_Scholar_Program_Prisma_Lopez

Play Fullscreen

2014 Amgen Tour of California Stage 7 Presented by Crunchies Natural Snacks - Highlights

Duration: 4:17
Updated: 14 Jul 2014
author: AmgenTourofCali

Stage 7.

http://wn.com/2014_Amgen_Tour_of_California_Stage_7_Presented_by_Crunchies_Natural_Snacks_-_Highlights

Play Fullscreen

Amgen Scholars Discover Their Potential

Duration: 2:51
Updated: 06 Jun 2013
author: Amgen

Amgen Scholars discuss how the Amgen Scholars Program helped them to "Discover Their Potential" in science. Amgen Scholars is a $34 million, eight-year progr...

http://wn.com/Amgen_Scholars_Discover_Their_Potential

Play Fullscreen

Science without Borders at Amgen / Ciência sem Fronteiras na Amgen

Duration: 4:27
Updated: 25 Aug 2014
author: Amgen

Amgen is a proud partner of the Brazilian Science without Borders initiative. Through its summer internship program, Amgen engages the scientists of tomorrow...

http://wn.com/Science_without_Borders_at_Amgen_Ciência_sem_Fronteiras_na_Amgen

Play Fullscreen

2013 Amgen Tour Of California Stage 1

Duration: 122:46
Updated: 14 May 2013

2013 Amgen Tour Of California Stage 1 Footage property of NBC Sports Network. No Copyright Infringement Intended.

http://wn.com/2013_Amgen_Tour_Of_California_Stage_1

Play Fullscreen

GoPro HD: AMGEN Tour of California 2012

Duration: 2:49
Updated: 24 Aug 2014
author: GoPro

Shot 100% on the HD HERO2® camera from http://GoPro.com Hit the road with the highlights from this year's AMGEN Tour of California. Music Pitch Twit, "Fine T...

http://wn.com/GoPro_HD_AMGEN_Tour_of_California_2012

Play Fullscreen

2014 Amgen Tour of California Stage 1 Presented by Visit California - Highlights

Duration: 5:39
Updated: 07 Jul 2014
author: AmgenTourofCali

Stage 1 Presented by Visit California - Sacramento.

http://wn.com/2014_Amgen_Tour_of_California_Stage_1_Presented_by_Visit_California_-_Highlights

Play Fullscreen

photo: AP / Tokyo Electric Power Co.

In this undated but recent photo released by Tokyo Electric Power Co., the Fukushima Daiichi Nuclear Power Plant reactors stand in line intact in Okumamachi in Fukushima Prefecture (state), northeastern Japan. Reactors encased in square boxes, from left, are: Unit 4, Unit 3, Unit 2, Unit 1, Unit 5 and Unit 6.

Edit

Magnitude 8.5 quake strikes off eastern Japan

Otago Daily Times

30 May 2015

A magnitude 8.5 earthquake struck off the east coast of Japan, shaking buildings in Tokyo, but there was no danger of a tsunami and no reports of damage since the quake was extremely deep. There were no reports of further irregularities at the Fukushima Dai-ichi nuclear plant, damaged four years ago in a massive 9.0 magnitude quake, or any other nuclear facilities ... "It shook violently ... She added that things on the island were normal ... ....

photo: AP / Khalid Mohammed

Iraqi security forces and allied Shiite militiamen prepare to attack Islamic State extremists in Tikrit, 80 miles (130 kilometers) north of Baghdad, Iraq, Tuesday, March 31, 2015.

Edit

Isis fighter was trained in counterterrorism by State Department, officials confirm

The Independent

30 May 2015

An Isis fighter, who has called for jihad in an online video, was trained in counterterrorism tactics by the United States State Department, officials have confirmed. Gulmurod Khalimov was an officer of the primary counterterrorism unit which responds to threats in Tajikistan, a State Department official said ... Western fighters join Kudish YPG in battle against Isis. State Department spokesperson Pooja Jhunjhunwala said ... --> ... ....

photo: AP / Ritchie B. Tongo

This areal photo taken through a glass window of a military plane shows China's alleged on-going reclamation of Mischief Reef in the Spratly Islands in the South China Sea Monday, May 11, 2015.

Edit

US demands immediate halt to South China Sea reclamations

Deccan Herald

30 May 2015

The United States today called for an "immediate and lasting halt" to reclamation works in disputed waters in the South China Sea, saying Beijing's behaviour in the area was "out of step" with international norms. "First, we want a peaceful resolution of all disputes ... "Yet, one country has gone much farther and much faster than any other. "And that's China ... And China did so in only the last 18 months," Carter said ... ....

photo: AP / Mehmet Shakir

File - In this picture taken on Saturday April 18, 2015, a Kurdish displaced family sit in the open air field near their house which was destroyed during the battle between the U.S. backed Kurdish forces and the Islamic State fighters, in Kobani, north Syria.

Edit

Isis in Palmyra: Civilians rounded-up and forced to watch execution of 20 men at amphitheatre

The Independent

28 May 2015

Isis rounded up civilians trapped in Palmyra and forced them to watch 20 people be executed in the historic city’s ancient amphitheatre, a Syrian monitoring group has claimed. The Britain-based Syrian Observatory for Human Rights said the men were accused of having fought for President Bashar Assad's army. It is not known how they were killed ... pic.twitter.com/7tgv1ajjjI ; frederic Helbert (@FredericHelbert) May 27, 2015 ... --> ... Sport ... News ... ....

photo: AP / Denis Balibouse

In this Monday, June 2, 2014 file photo, German test pilot Markus Scherdel steers the solar-powered Solar Impulse 2 aircraft for its maiden flight at its base in Payerne, Switzerland.

Edit

Solar Impulse plane starts six-day Pacific Ocean crossing powered only by the sun

The Guardian

31 May 2015

Seventh and longest section of round-the-world journey will require pilot Andre Borschberg to survive on little sleep and with only a parachute for backup. Solar Impulse 2 takes off from Nanjing Airport, China. Pilot Andre Borschberg will fly a six-day non-stop flight over the Pacific Ocean to Hawaii. Photograph. Feature China / Barcroft Media/Feature China / Barcroft Media. Agence France-Presse in Nanjing. Sunday 31 May 2015 03.19 BST ... ....

« back to news headlines

Edit

Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (carfilzomib) in Patients With Relapsed And Refractory ...

StreetInsider

31 May 2015

Visit StreetInsider.com at http.//www.streetinsider.com/Press+Releases/Amgen+Initiates+Phase+3+Study+Evaluating+Once-Weekly+Kyprolis%C2%AE+%28carfilzomib%29+in+Patients+With+Relapsed+And+Refractory+Multiple+Myeloma/10609664.html for the full story. ....

Edit

Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (carfilzomib) in Patients With Relapsed And Refractory Multiple Myeloma Data from Once-Weekly CHAMPION Phase 1/2 Study Presented at ASCO

PR Newswire

31 May 2015

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors ... including Amgen Inc.'s most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K....

Edit

Amgen Tour of California 2015 - Photos by Dana Gardner

Big News Network

31 May 2015

.FirstPlace {. color. #F00;. font-weight. bold;. }. .Runnersup {. color. #0080FF;. font-weight. bold;. } ... ....

Edit

Amgen launches program to further advance basic biology research

Big News Network

30 May 2015

Amgen has announced the creation of a catalog of qualified tools and reagents available to academic institutions to help further research and advance basic discoveries in biology, as well as deepen ... ....

Edit

J&J; multiple myeloma drug offers hope after others stop working: study

Reuters

30 May 2015

n">An experimental biotech drug being developed by Johnson & Johnson may offer hope to multiple myeloma patients who have run out of options, according to data from a midstage study released at a cancer meeting on Saturday ... They had become resistant, or failed to respond, to Takeda's Velcade and Celgene's Revlimid, the most widely-used myeloma medicines, as well as newer drugs Kyprolis from Amgen and Celgene's Pomalyst ... Reuters ... X. ....

Edit

J&J; multiple myeloma drug offers hope after others stop working -study

Reuters

30 May 2015

n">May 30 An experimental biotech drug being developed by Johnson & Johnson may offer hope to multiple myeloma patients who have run out of options, according to data from a midstage study released at a cancer meeting on Saturday ... They had become resistant, or failed to respond, to Takeda's Velcade and Celgene's Revlimid, the most widely-used myeloma medicines, as well as newer drugs Kyprolis from Amgen and Celgene's Pomalyst ... Reuters....

Edit

Johnson & Johnson's experimental biotech drug looks promising

Business Insider

30 May 2015

See Also ... J&J plans to use the Phase II study to seek U.S. and European approval of its antibody daratumumab to treat the blood cancer. The drug received breakthrough designation from the U.S ... They had become resistant, or failed to respond, to Takeda's Velcade and Celgene's Revlimid, the most widely-used myeloma medicines, as well as newer drugs Kyprolis from Amgen and Celgene's Pomalyst ... Read the original article on Reuters ... Loading....

Edit

Amgen and Caltech Establish Partnership in Health Sciences (California Institute of Technology)

noodls

29 May 2015

Caltech and Amgen have joined forces in the pursuit of foundational discoveries in the biological sciences through a multifaceted new partnership spanning research, graduate student training, and shared resources. "The work we do is built upon the foundation of basic discoveries in biology," says Alexander Kamb (PhD '88), Amgen's senior vice president of Discovery Research....

Edit

Amgen (AMGN) Announces Two AMG 416 Phase 3s Met Primary Endpoints in CKD

StreetInsider

29 May 2015

Visit StreetInsider.com at http.//www.streetinsider.com/Corporate+News/Amgen+%28AMGN%29+Announces+Two+AMG+416+Phase+3s+Met+Primary+Endpoints+in+CKD/10606482.html for the full story. ....

Edit

Amgen (AMGN), Merck (MRK) Expand Talimogene Taherparepvec Combo Collaboration in SCCHN

StreetInsider

29 May 2015

Visit StreetInsider.com at http.//www.streetinsider.com/Corporate+News/Amgen+%28AMGN%29%2C+Merck+%28MRK%29+Expand+Talimogene+Taherparepvec+Combo+Collaboration+in+SCCHN/10606909.html for the full story. ....

Edit

Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease (Amgen Inc)

noodls

29 May 2015

Amgen Inc). THOUSAND OAKS, Calif., May 29, 2015 /PRNewswire/ -- Amgen (NASDAQ ... About Amgen ... Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K ... Amgen, Thousand Oaks....

Edit

Amgen And Merck Announce Expansion Of Collaboration To Support Studies Of Talimogene Laherparepvec In Combination With KEYTRUDA® (Pembrolizumab) In Patients With Head And Neck Cancer (Amgen Inc)

noodls

29 May 2015

Amgen Inc) ... and KENILWORTH, N.J., May 29, 2015 /PRNewswire/ -- Amgen (NASDAQ ... About Amgen ... Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen Inc., including Amgen Inc.'s most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K ... SOURCE Amgen....

Edit

Amgen And Merck Announce Expansion Of Collaboration To Support Studies Of Talimogene Laherparepvec In Combination With KEYTRUDA® (Pembrolizumab) In Patients With Head And Neck Cancer Companies Also Plan to Initiate Phase 3 Trial in Combination for Advanced Melanoma

PR Newswire

29 May 2015

and its subsidiaries (Amgen) and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating ......